Table 4.
Relievement of symptoms in RECOVEREEZ FORTE™ group and control group
| Group | Category | Variables | Fever, n (%) | Cough, n (%) | Sore throat, n (%) | Breathlessness, n (%) |
|---|---|---|---|---|---|---|
| RECOVEREEZ FORTE™ (n = 32) | Young adults (18–35) (n = 11) | Present on day 0 | 7 (63.64%) | 10 (90.91%) | 9 (81.81%) | 8 (72.73%) |
| Absent by day 2 | 1 (14.29%) | 0 (0%) | 2 (22.22%) | 2 (25%) | ||
| Absent by day 5 | 5 (71.43%) | 4 (40%) | 4 (44.44%) | 2 (25%) | ||
| Absent by day 7 | 0 (0%) | 3 (30%) | 3 (33.33%) | 1 (12.5%) | ||
| Absent by day 10 | 1 (14.29%) | 3 (30%) | 0 (0%) | 2 (25%) | ||
| Not negative by day 10 | 0 (0%) | 0 (0%) | 0 (0%) | 1 (12.5%) | ||
| Middle age (36–55) (n = 18) | Present on day 0 | 12 (66.67%) | 13 (72.22%) | 9 (50%) | 4 (22.22%) | |
| Absent by day 2 | 5 (41.67%) | 0 (0%) | 0 (0%) | 0 (0%) | ||
| Absent by day 5 | 5 (41.67%) | 4 (30.77%) | 3 (33.33%) | 2 (50%) | ||
| Absent by day 7 | 1 (8.33%) | 7 (53.85%) | 5 (55.56%) | 2 (50%) | ||
| Absent by day 10 | 1 (8.33%) | 1 (7.69%) | 1 (11.11%) | 0 (0%) | ||
| Not negative by day 10 | 0 (0%) | 1 (7.69%) | 0 (0%) | 0 (0%) | ||
| Old age (above 56) (n = 3) | Present on day 0 | 3 (100%) | 3 (100%) | 1 (33.33%) | 1 (33.33%) | |
| Absent by day 2 | 1 (33.33%) | 0 (0%) | 0 (0%) | 0 (0%) | ||
| Absent by day 5 | 2 (66.67%) | 2 (66.67%) | 1 (100%) | 0 (0%) | ||
| Absent by day 7 | 0 (0%) | 1 (33.33%) | 0 (0%) | 1 (100%) | ||
| Absent by day 10 | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | ||
| Not negative by day 10 | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | ||
| Control (n = 32) | Young adults (18–35) (n = 13) | Present on day 0 | 10 (76.92%) | 7 (53.85%) | 8 (61.54%) | 5 (45.45%) |
| Absent by day 2 | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | ||
| Absent by day 5 | 2 (20%) | 1 (14.29%) | 1 (12.5%) | 0 (0%) | ||
| Absent by day 7 | 5 (50%) | 2 (28.57%) | 5 (62.5%) | 3 (60%) | ||
| Absent by day 10 | 3 (30%) | 4 (57.14%) | 2 (25%) | 2 (40%) | ||
| Not negative by day 10 | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | ||
| Middle age (36–55) (n = 13) | Present on day 0 | 8 (61.54%) | 9 (69.23%) | 7 (53.84%) | 4 (22.22%) | |
| Absent by day 2 | 0 (0%) | 0 (0%) | 0 (%) | 0 (0%) | ||
| Absent by day 5 | 1 (12.5%) | 1 (11.11%) | 0 (%) | 0 (0%) | ||
| Absent by day 7 | 1 (12.5%) | 5 (55.56%) | 3 (42.86%) | 1(25%) | ||
| Absent by day 10 | 6 (75%) | 3 (33.33%) | 2 (28.57%) | 0 (0%) | ||
| Not negative by day 10 | 0 (0%) | 0 (0%) | 2 (28.57%) | 3 (75%) | ||
| Old age (above 56) (n = 6) | Present on day 0 | 6 (100%) | 4 (66.67%) | 2 (33.33%) | 2 (33.33%) | |
| Absent by day 2 | 1 (16.67%) | 0 (0%) | 0 (0%) | 0 (0%) | ||
| Absent by day 5 | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | ||
| Absent by day 7 | 3 (50%) | 2 (50%) | 0 (0%) | 1 (50%) | ||
| Absent by day 10 | 1 (16.67%) | 1 (25%) | 1 (50%) | 1 (50%) | ||
| Not negative by day 10 | 1 (16.67%) | 1 (25%) | 1 (50%) | 0 (0%) |
Number of patients who showed recovery from symptoms by day 2, 5, 7 and 10